Managing obstetric and gynecologic complications in obese women: Evidence-Based Strategies for Optimizing Outcomes and Reducing Risks
Abstract
Introduction: Obesity among reproductive-aged women increases the risk of gestational diabetes, preeclampsia, menstrual disorders, infertility, and delivery complications. Despite rising global obesity rates, clinical guidelines often lack comprehensive management strategies. This review examines evidence-based approaches to optimize maternal and gynecologic outcomes through multidisciplinary care.
Methods: A comprehensive literature review was conducted on obesity-related obstetric and gynecologic complications, including national and international guidelines, clinical trials, and observational studies. Key management strategies such as preconception care, lifestyle interventions, pharmacologic therapies, surgical treatments, and digital health solutions were analyzed.
Results: Obesity is linked to multiple adverse maternal outcomes, including increased rates of gestational diabetes, preeclampsia, prolonged labor, postpartum hemorrhage, and fetal complications. Gynecologic conditions such as polycystic ovary syndrome, endometrial hyperplasia, and infertility are also exacerbated by obesity-related metabolic changes. Effective management strategies involve a combination of preconception weight loss interventions, structured gestational monitoring, pharmacologic treatments, and surgical approaches like bariatric surgery for high-risk cases. Telehealth interventions and digital health solutions provide an opportunity to bridge the gap in healthcare access, particularly in…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.